Risk Management


<< Back
Share
 Print

Giant Cell Arteritis: Delayed diagnosis and treatment

August 17, 2022

Dear OMIC Insureds:

OMIC is pleased to announce the release of our newest Digest:

Giant Cell Arteritis: Delayed diagnosis and treatment

  • Highlights recent claims data, explores new case studies, and offers risk management recommendations
  • Gives you links to practical GCA risk management tools:
  • Updated GCA Checklist
  • New GCA Patient Information Sheet with Consent to/Refusal of Treatment
  • Includes news from OMIC’s Chair, Dan Briceland, MD
  • Provides updated information about liability and coverage issues related to patient falls

 

If you have questions, contact us for confidential risk management advice at riskmanagement@omic.com. Or call us at 1-800-562-6642, enter 4 for Risk Management.

Sincerely,

Jane Mock, CPHRM
OMIC Risk Manager

______________________________________________

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Expertise unmatched.

OMIC's sole mission is to serve ophthalmology. The premier source of ophthalmic claims data and loss prevention materials, OMIC's member hotline is the most used ophthalmic consultative service of its kind and OMIC.com is the most visited web site in America for ophthalmic risk management advice and patient consent documents.

61864684